| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1146075K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0146075 |
| P932 | PMC publication ID | 4711576 |
| P698 | PubMed publication ID | 26730981 |
| P5875 | ResearchGate publication ID | 289488788 |
| P50 | author | Ulf Schönermarck | Q46747534 |
| P2093 | author name string | Jens Werner | |
| Markus Guba | |||
| Bruno Meiser | |||
| Andrea Dick | |||
| Antje Habicht | |||
| Michael Fischereder | |||
| Manfred Stangl | |||
| Teresa Kauke | |||
| Sandra Klimaschewski | |||
| P2860 | cites work | Detection and clinical relevance of donor specific HLA antibodies: a matter of debate | Q26998713 |
| BK virus nephropathy--polyomavirus adding insult to injury | Q28218151 | ||
| BK virus in solid organ transplant recipients: an emerging syndrome | Q34451180 | ||
| Polyomavirus BK. | Q35548648 | ||
| Outcomes of ABO-incompatible kidney transplantation in the United States | Q35822937 | ||
| Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients | Q36126901 | ||
| Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations | Q36136619 | ||
| BK virus: opportunity makes a pathogen | Q36188861 | ||
| Banff 2011 Meeting report: new concepts in antibody-mediated rejection | Q37058043 | ||
| Current approaches to the management of highly sensitized kidney transplant patients | Q37836967 | ||
| Luminex and antibody detection in kidney transplantation | Q38007085 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab | Q42227841 | ||
| Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis | Q42277289 | ||
| A prospective longitudinal study of BK virus infection in 104 renal transplant recipients | Q43603996 | ||
| Analysis of the renal transplant waiting list: application of a parametric competing risk method | Q43997502 | ||
| Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs | Q44441935 | ||
| Five-year outcomes in living donor kidney transplants with a positive crossmatch. | Q45351621 | ||
| Rituximab and intravenous immune globulin for desensitization during renal transplantation | Q46477840 | ||
| Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. | Q47705702 | ||
| Desensitization in HLA-incompatible kidney recipients and survival. | Q51018759 | ||
| Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. | Q53528863 | ||
| Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. | Q54481297 | ||
| Time Course of Pathologic Changes in Kidney Allografts of Positive Crossmatch HLA-Incompatible Transplant Recipients | Q58048141 | ||
| No Association of Kidney Graft Loss With Human Leukocyte Antigen Antibodies Detected Exclusively by Sensitive Luminex Single-Antigen Testing: A Collaborative Transplant Study Report | Q59305666 | ||
| Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss | Q77312467 | ||
| Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis | Q78571279 | ||
| Pretransplant risk assessment in renal allograft recipients using virtual crossmatching | Q79921631 | ||
| Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients | Q81137752 | ||
| Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation | Q83401607 | ||
| New approaches for optimizing transplant of sensitized patients | Q84568124 | ||
| ABO-incompatible kidney transplantation | Q84820579 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | desensitization | Q2700499 |
| P304 | page(s) | e0146075 | |
| P577 | publication date | 2016-01-05 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience | |
| P478 | volume | 11 |
| Q90252745 | ABO-Incompatible Kidney Transplant Outcomes: A Meta-Analysis |
| Q91657061 | Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study |
| Q48112929 | Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. |
| Q47340562 | The effect of desensitization therapy in kidney transplantation |
Search more.